Previous psychedelic research has shown that a handful of entheogens hold great power over these psychological states. Based on these findings, the psychedelics-focused biotech company Cybin and the University of Washington are putting together a randomized, placebo-controlled clinical trial that will harness the power of psilocybin alongside psychotherapy sessions.
Psilocybin mushrooms are strutting their stuff when it comes to anxiety, depression, and OCD. DMT research continues to show promise when it comes to generating new brain cellsand rehabilitating stroke patients. LSD might help addicts break free from their chains.
The research team primarily aims to investigate the effectiveness of psilocybin-assisted psychotherapy against depression, anxiety, burnout, and post-traumatic stress. As well as offering brave frontline workers potential relief from their experiences, this research marks another step forward in the utilization of psychedelics to heal the human psyche from traumatic and painful experiences.
Dr Anthony Black, the lead researcher of the trial, commented on the ground-breaking nature of the study, stating, “There is tremendous potential in a collaboration between the University of Washington and Cybin to move the field forward, and this project is an incredibly valuable initial step towards a productive future”.